Patients
Patients and carers are our #1 priority and essential
in every decision we make as a company.
What you need to know about our trial
-
RSO-021 drug is for patients that have exhausted first line therapy for mesothelioma and metastatic disease with pleural effusion
-
You’ll need an IPC (intrapleural catheter) or are willing to get an IPC
-
The drug is delivered weekly
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Call the Freephone Support Line
on 0800 169 2409
or email support@mesothelioma.uk.com.
The opening hours of the information line are
9am to 4pm Monday to Friday.